Healthcare Industry News

 With the increasing prevalence of various chronic diseases and the surging costs of healthcare and patient care across the world, the demand for healthcare insurance is growing rapidly. A healthcare insurance covers the surgical and medical expenses incurred during the treatment of the insured individual. Moreover, a healthcare insurance can reimburse the various expenses incurred during the treatment of the injury or illness or directly pay the healthcare providers for the treatment of the insured person. On the other hand, disease insurance is used for covering the expenses incurred during the treatment of specific diseases, injuries, and illnesses such as cancer, paralysis, heart attack, sclerosis, kidney failure, and coma. This insurance provides coverage in cases of different medical events or disease diagnosis. Under the income protection policy, a fixed and regular replacement of income is provided if the insured individual is not able to work because of an illness or injury. B

The prevalence of diseases across the globe has been rising rapidly. Incidence of cardiovascular and respiratory diseases, especially, are on the rise due to the changing lifestyle of people and growing consumption of tobacco among people. Patients suffering from these diseases often need to go through surgical procedures for the management of diseases. Between medical gas and medical gas equipment, the demand for medical gases has been higher in medical settings and the situation is expected to remain the same in the coming years as well. Two types of medical gases are utilized in healthcare settings, namely pure medical gas (including helium, oxygen, carbon dioxide, nitrous oxide, nitrogen, and medical air medical gas) and medical gas mixture (including ethylene oxide, blood gas, helium oxygen, lung diffusion, anaerobic, nitrous oxide-oxygen, laser, and carbon dioxide-oxygen mixture). Other than this, medical gas equipment is of different types as well, namely medical gas delivery

  For many people in Europe, especially emotionally disturbed teens, drugs are their best friends! But, as everyone knows, whether an addict or not, drugs are not good. Though they help people escape their troubles for a while, they lead to long-lasting ill-effects, such as risk of AIDS and hepatitis C. Due to the increasing concerns among relatives and friends about drug abuse by their loved ones, they are rapidly using methods to test the presence of such substances in the body of suspected users. Thus, with the rising prevalence of drug abuse in the continent, the European drug of abuse testing market is predicted to grow to $3.0 billion by 2023, from $1.7 billion revenue in 2017, at a 9.6% CAGR during 2018–2023. Such kits and products can be used to determine the presence of a number of toxicants in the body, including amphetamines, opiates, alcohol, cannabis, cocaine, and ecstasy, commonly known as MDMA, which is short for its chemical formula 3,4-methyl ​ enedioxy ​ methamph

 The Bureau of Economic Analysis (BEA), the U.S. Department of Commerce, states that the personal disposable income of the U.S. populace increased from $17,595.7 billion in the third quarter (Q3) in 2020 to $18,174.1 billion in Q3 of 2021. Likewise, the Reserve Bank of India (RBI) states that the gross national disposable income of the people of India grew from INR 1,92,62,652 crore in the financial year (FY) 2018–2019 to INR 2,06,30,319 crore in the FY 2019–2020. The soaring disposable income of people is encouraging them to use advanced technologies to improve their physical experience.  Thus, the rising disposable income along with the growing geriatric population will help the facial skin ablative treatment market exhibit a CAGR of 7.8% during 2020–2030. According to P&S Intelligence, the market was valued at $4,134.6 million in 2019 and it will generate $8,394.3 million revenue by 2030. As aging causes wrinkles and fine lines, old people are one of the prominent users of faci

The global generic drugs market reached $278.4 billion revenue in 2019, and it will advance at a CAGR of 10.0% during 2020–2030 (forecast period), as per the estimates of the market research company, P&S Intelligence. Furthermore, the market is expected to generate a revenue of $786.0 billion by 2030. The market is being driven by the surging geriatric population, surging incidence of patent expiration of branded drugs, growing prevalence of acute and chronic diseases, and soaring research and development (R&D) expenditure of pharma and biotech companies.  As per a report published by the World Health Organization (WHO), people nowadays are living longer and the average life expectancy across the world has grown massively over the last few years. This has caused a sharp surge in the global geriatric population. According to the World Population Aging 2020 report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65